<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6</volume><submitter>Joyce OC</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Several measures of cardiovascular health have been investigated as potential risk factors for development of cognitive decline in mid-to later-life, among them, circulating cholesterol. However, the efficacy of midlife interventions aimed at reducing blood cholesterol to mitigate the risk of cognitive decline is uncertain, with conflicting evidence reported from a range of longitudinal and cross-sectional studies. This review systematically investigates the connection between cholesterol measures in midlife and their impact on cognitive function in both mid- and later-life.&lt;h4>Methods&lt;/h4>Electronic databases were explored from their inception until December 2023. Studies that evaluated the relationship between cholesterol and its sub-components in midlife (40-65 year</pubmed_abstract><journal>Frontiers in aging</journal><pagination>1430382</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11962029</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The influence of circulating cholesterol and its components in middle-aged adults on cognitive function at mid- and later-life; a systematic review.</pubmed_title><pmcid>PMC11962029</pmcid><pubmed_authors>McHugh C</pubmed_authors><pubmed_authors>Wilson F</pubmed_authors><pubmed_authors>Joyce OC</pubmed_authors><pubmed_authors>Mockler D</pubmed_authors><pubmed_authors>Kelly AM</pubmed_authors></additional><is_claimable>false</is_claimable><name>The influence of circulating cholesterol and its components in middle-aged adults on cognitive function at mid- and later-life; a systematic review.</name><description>&lt;h4>Introduction&lt;/h4>Several measures of cardiovascular health have been investigated as potential risk factors for development of cognitive decline in mid-to later-life, among them, circulating cholesterol. However, the efficacy of midlife interventions aimed at reducing blood cholesterol to mitigate the risk of cognitive decline is uncertain, with conflicting evidence reported from a range of longitudinal and cross-sectional studies. This review systematically investigates the connection between cholesterol measures in midlife and their impact on cognitive function in both mid- and later-life.&lt;h4>Methods&lt;/h4>Electronic databases were explored from their inception until December 2023. Studies that evaluated the relationship between cholesterol and its sub-components in midlife (40-65 year</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2025-07-11T03:04:01.559Z</modification><creation>2025-07-11T03:04:01.559Z</creation></dates><accession>S-EPMC11962029</accession><cross_references><pubmed>40177626</pubmed><doi>10.3389/fragi.2025.1430382</doi></cross_references></HashMap>